HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effects of acute and repeated electrically and chemically induced seizures on [3H]Nimodipine and [125I]omega-conotoxin GVIA binding in rat brain.

Abstract
[3H]Nimodipine and high-affinity [125I]omega-conotoxin GVIA (CgTX) binding were investigated in membranes from rat cerebral cortex, cerebellum, and hippocampus after electrically and chemically induced seizures. Animals were decapitated 30 min after a single electroconvulsive shock (ECS) or lidocaine-induced seizure and 24 h after the last of 10 once-daily ECS or six once-daily lidocaine-induced seizures. After a single ECS, [3H]nimodipine and [125I]CgTX binding sites decreased in cerebral cortex (by 10% and 17%, respectively). A downregulation of [3H]nimodipine binding sites in hippocampus occurred after single and repeated lidocaine-induced seizures (by 24% and 11%, respectively), whereas [125I]CgTX binding remained unaltered. An earlier report on changes in [3H]nitrendipine binding after chronic ECS in cortex and hippocampus was not confirmed.
AuthorsC H Gleiter, C J Cain, S R Weiss, R M Post, P J Marangos
JournalEpilepsia (Epilepsia) 1989 Jul-Aug Vol. 30 Issue 4 Pg. 487-92 ISSN: 0013-9580 [Print] United States
PMID2753000 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Iodine Radioisotopes
  • Mollusk Venoms
  • Tritium
  • Nimodipine
  • omega-Conotoxin GVIA
  • Lidocaine
Topics
  • Animals
  • Binding Sites
  • Brain (metabolism)
  • Calcium Channel Blockers (metabolism)
  • Cerebellum (metabolism)
  • Cerebral Cortex (metabolism)
  • Electroshock
  • Hippocampus (metabolism)
  • Iodine Radioisotopes
  • Lidocaine
  • Male
  • Mollusk Venoms (metabolism)
  • Nimodipine (metabolism)
  • Rats
  • Rats, Inbred Strains
  • Seizures (chemically induced, etiology, metabolism)
  • Tritium
  • omega-Conotoxin GVIA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: